Shimadzu announces the release of its C2MAP™-2000 automated pretreatment module for cell culture media analysis. This product is for pretreating culture media samples by adding reagents, such as a deproteinizing agent or internal standard substance, filtering precipitated proteins, and diluting samples. The C2MAP system combines the C2MAP-2000 module with a Shimadzu ultra-fast liquid chromatograph mass […]
CAMBRIDGE, England CS Genetics Limited, a developer of tools and techniques for genomics, was granted its first patent (GB 2,539,675 B) on 22 November 2017. CS Genetics is developing Coding Strand Sequencing™: a platform for instrument-free, solution-phase indexing of nucleic acids. Coding Strand Sequencing™ uses a new class of macromolecular indexing tool called Coding Strands™ to tag […]
Location: Cambridge First-to-market cfDNA Reference Standard specific for EGFR gene mutations adds to Horizon’s existing portfolio of cfDNA controls Horizon’s EGFR Multiplex cfDNA Reference Standard allows laboratories to optimize, validate and routinely monitor performance of PCR-based tests, NGS, and other novel assays Covers EGFR mutations implicated in the responsiveness to EGFR tyrosine kinase inhibitors and […]
Emeryville, Calif. – Berkeley Lights, Inc. (BLI), a company dedicated to creating transformational platforms for biopharmaceutical processes, today announced the appointment of five leading experts from top academic, research and life sciences and engineering organizations to its Strategic Scientific Advisory Board (SSAB). The SSAB serves as a strategic resource for Berkeley Lights as it continues to […]
Pioneer of real-time cell analysis instrumentation will join forces with leading provider of iPSC-derived cardiomyocytes SAN DIEGO ACEA Biosciences (ACEA), a pioneer and leader in label-free real-time cell analysis instrumentation, and Ncardia, a leading expert in human cardiovascular stem cell technology, disease modelling and cell-based assay products and services, announced today that they have established […]
PARIS Aenitis Technologies, which develops new medical equipment based on acoustic manipulation of biological particles, today announced that it has received €4 million in funding, following its application to the highly-selective SME Instrument Phase 2 European programme, in the “Healthcare Biotechnology” category. SME Instrument Phase 2 is part of Horizon 2020, a programme managed by […]
Emeryville, Calif. – Berkeley Lights, Inc. (BLI), a company dedicated to bringing to market transformational platforms for biopharmaceutical processes, announced today that Teva Pharmaceuticals Australia, Pty. Ltd. has implemented BLI’s Beacon platform in their antibody discovery programs. The Beacon platform is capable of screening thousands of antibody producing cells in less than a day. Cell characterizations […]
SAN DIEGO, CA — NanoCellect Biomedical Inc., a developer of microfluidic cell sorting technologies for cell based assays, today announced the completion of a $10 million Series B financing round, including convertible notes. The financing included the participation of new investors Illumina Ventures, Anzu Partners, Vertical Venture Partners, and 5 Prime Ventures. Also participating in […]
Sphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, and Geneva Biotech, an EMBL spin-out developing world-class viral and non-viral DNA delivery systems, have received a €1.6 million grant from Eurostars. The funding will be used to develop large DNA cargo gene delivery and genome engineering systems. The Eurostars funding programme […]
New cas9 protein and synthetic gRNA strengthen Thermo Fisher Scientific’s portfolio of genome editing products CARLSBAD, Calif., — As researchers continue their quest to create more relevant cellular models, they now have access to a comprehensive portfolio of solutions from Thermo Fisher Scientific designed to maximize the performance of their genome editing experiments. Solutions in the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
